UK markets open in 6 hours 57 minutes

Nicox S.A. (0RCQ.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
0.4595-0.0015 (-0.33%)
At close: 10:18AM GMT
Full screen
Previous close0.4610
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0000 - 0.0000
52-week range
Volume4
Avg. volume353
Market cap133,047
Beta (5Y monthly)0.89
PE ratio (TTM)N/A
EPS (TTM)-1.1670
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Number of voting rights as of April 30, 2023

    Nicox SA Société anonyme with a registered capital of € 50,156,698 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On May 3, 2023, MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS (Article L.233-8 II of the Code de Commerce and Articles 221-1 and 223-16 of the Règlement général of the l’AMF) As of April 30, 2023 Total number of shares composing the share capital 50,156,698Total

  • Globe Newswire

    Nicox’s Partner Ocumension Therapeutics Receives Priority Review Status for ZERVIATE New Drug Application in China

    Press ReleaseNicox’s Partner Ocumension Therapeutics Receives Priority Review Status for ZERVIATE New Drug Application in China Nicox’s partner, Ocumension Therapeutics, announced on April 26, 2023, that they had received Priority Review Status for the New Drug Application for ZERVIATE in ChinaAccelerates the ZERVIATE® approval and launch, which are expected in China in 2024 April 28, 2023 – release at 7:30 am CET Sophia Antipolis, FranceNicox SA (Euronext Paris: FR0013018124, COX), an internati

  • Globe Newswire

    Transfer of Nicox’s shares to Euronext Growth Paris effective on April 28, 2023

    Press Release Transfer of Nicox’s shares to Euronext Growth Paris effective on April 28, 2023 April 26, 2023 – release at 9:00 am CETSophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that the transfer of the listing of the securities issued by the Company from the Euronext Paris regulated market (compartment C) to the Euronext Growth Paris multilateral trading facility (the “Transfer”), will be effective as from the tra